Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

EZ-ALBI Score for Predicting Hepatocellular Carcinoma Prognosis
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, et al.
Liver Cancer (2020) Vol. 9, Iss. 6, pp. 734-743
Open Access | Times Cited: 51

Showing 1-25 of 51 citing articles:

The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
Michel Ducreux, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab, et al.
ESMO Open (2023) Vol. 8, Iss. 3, pp. 101567-101567
Open Access | Times Cited: 90
Newly Developed Modified ALBI Grade Shows Better Prognostic and Predictive Value for Hepatocellular Carcinoma
Masatoshi Kudo
Liver Cancer (2021) Vol. 11, Iss. 1, pp. 1-8
Open Access | Times Cited: 44
Shape Designed Implanted Drug Delivery System for In Situ Hepatocellular Carcinoma Therapy
Chaochao Zhao, Qin Shi, Hu Li, et al.
ACS Nano (2022) Vol. 16, Iss. 5, pp. 8493-8503
Closed Access | Times Cited: 29
Comparison of Four Albumin-Based Liver Reserve Models (ALBI/EZ-ALBI/PALBI/PAL) against MELD for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization
Shu‐Yein Ho, Po‐Hong Liu, Chia-Yang Hsu, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 1925-1925
Open Access | Times Cited: 14
Prognostic nutritional index as a prognostic factor for very early-stage hepatocellular carcinoma
Chun-Ting Ho, Elise Chia‐Hui Tan, Pei‐Chang Lee, et al.
Clinical and Translational Gastroenterology (2024)
Open Access | Times Cited: 5
Predicting Post-Hepatectomy Liver Failure in HCC Patients: A Review of Liver Function Assessment Based on Laboratory Tests Scores
Alessio Morandi, Matteo Risaliti, Michele Montori, et al.
Medicina (2023) Vol. 59, Iss. 6, pp. 1099-1099
Open Access | Times Cited: 13
Interpretations of the Role of Plasma Albumin in Prognostic Indices: A Literature Review
Kim Oren Gradel
Journal of Clinical Medicine (2023) Vol. 12, Iss. 19, pp. 6132-6132
Open Access | Times Cited: 12
Predictive power of ALBI score-based nomogram for 30-day mortality following transcatheter aortic valve implantation
Abdullah Yıldırım, Ömer Genç, Mert Evlıce, et al.
Biomarkers in Medicine (2025), pp. 1-12
Closed Access
Egyptian Society of Liver Cancer Recommendation Guidelines for the Management of Hepatocellular Carcinoma
Ashraf Omar, Ahmed O. Kaseb, Tamer Elbaz, et al.
Journal of Hepatocellular Carcinoma (2023) Vol. Volume 10, pp. 1547-1571
Open Access | Times Cited: 10
Survival of patients with non-viral hepatocellular carcinoma treated with trans-arterial chemoembolization: A multicenter cohort study
Hend Ibrahim Shousha, Eman Barakat, Eman Rewisha, et al.
Arab Journal of Gastroenterology (2025)
Closed Access
Nomogram for predicting early cancer-related death due to recurrence after liver resection in hepatocellular carcinoma patients with Barcelona Clinic Liver Cancer (BCLC) stage B/C: a multicenter study
Zhan-Cheng Qiu, Haozheng Cai, Youwei Wu, et al.
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access
Easy albumin–bilirubin score as a new prognostic predictor in hepatocellular carcinoma
Shu‐Yein Ho, Po‐Hong Liu, Chia‐Yang Hsu, et al.
Hepatology Research (2021) Vol. 51, Iss. 11, pp. 1129-1138
Open Access | Times Cited: 21
Prognostic Prediction for Patients with Hepatocellular Carcinoma and Ascites: Role of Albumin-Bilirubin (ALBI) Grade and Easy (EZ)-ALBI Grade
Jia‐I Liao, Shu‐Yein Ho, Po‐Hong Liu, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 753-753
Open Access | Times Cited: 8
Efficacy and safety of cabozantinib for patients with advanced hepatocellular carcinoma based on albumin-bilirubin grade
Robin Kate Kelley, Rebecca A. Miksad, İrfan Çiçin, et al.
British Journal of Cancer (2021) Vol. 126, Iss. 4, pp. 569-575
Open Access | Times Cited: 20
Changing the Treatment Paradigm for Hepatocellular Carcinoma Using Atezolizumab plus Bevacizumab Combination Therapy
Masatoshi Kudo
Cancers (2021) Vol. 13, Iss. 21, pp. 5475-5475
Open Access | Times Cited: 20
Validation and prognostic value of EZ-ALBI score in patients with intermediate-stage hepatocellular carcinoma treated with trans-arterial chemoembolization
Prooksa Ananchuensook, Supachaya Sriphoosanaphan, Sirinporn Suksawatamnauy, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 13
Combination of neutrophil/lymphocyte ratio and albumin/bilirubin grade as a prognostic predictor for hepatocellular carcinoma patients undergoing curative hepatectomy
Hao Luo, Chongming Huang, Meng Meng, et al.
BMC Gastroenterology (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 7
Chronological change in serum albumin as a prognostic factor in patients with hepatocellular carcinoma treated with lenvatinib: proposal of albumin simplified grading based on the modified albumin–bilirubin score (ALBS grade)
Kazuya Kariyama, Atsushi Hiraoka, Takashi Kumada, et al.
Journal of Gastroenterology (2022) Vol. 57, Iss. 8, pp. 581-586
Closed Access | Times Cited: 12
Cryptogenic hepatocellular carcinoma: characteristics, outcome, and prognostic role of albumin-bilirubin (ALBI) grade vs easy ALBI grade
Shu‐Yein Ho, Mei-Hsia Yuan, Po‐Hong Liu, et al.
Scandinavian Journal of Gastroenterology (2022) Vol. 58, Iss. 1, pp. 61-69
Closed Access | Times Cited: 9
On-Treatment Albumin-Bilirubin Grade: Predictor of Response and Outcome of Sorafenib-Regorafenib Sequential Therapy in Patients with Unresectable Hepatocellular Carcinoma
Hung‐Wei Wang, Po‐Heng Chuang, Wen‐Pang Su, et al.
Cancers (2021) Vol. 13, Iss. 15, pp. 3758-3758
Open Access | Times Cited: 12
Improvement of Type 2 Diabetes Mellitus and Attenuation of NAFLD Are Associated with the Success of Obesity Therapy
Andreas Schmid, Miriam Arians, Thomas Karrasch, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 7, pp. 1756-1756
Open Access | Times Cited: 8
Tumor burden score as a new prognostic surrogate in patients with hepatocellular carcinoma undergoing radiofrequency ablation: role of albumin-bilirubin (ALBI) grade vs easy ALBI grade
Shu‐Yein Ho, Po‐Hong Liu, Chia-Yang Hsu, et al.
Expert Review of Gastroenterology & Hepatology (2022) Vol. 16, Iss. 9, pp. 903-911
Closed Access | Times Cited: 8
The outcomes and prognostic factors of patients with hepatocellular carcinoma and Child-Turcotte-Pugh class B
Chia‐Chu Fu, Yu-Jen Chen, Chien‐Wei Su, et al.
Journal of the Chinese Medical Association (2023)
Open Access | Times Cited: 4
Albumin-Based Liver Reserve Models vs. MELD 3.0 in Prognostic Prediction for Hepatocellular Carcinoma Patients with Renal Insufficiency
Shu‐Yein Ho, Po‐Hong Liu, Chia-Yang Hsu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16987-16987
Open Access | Times Cited: 4
The assessment of impaired liver function and prognosis in hepatocellular carcinoma
Roxana Pantea, Jan Bednarsch, Sophia M. Schmitz, et al.
Expert Review of Gastroenterology & Hepatology (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top